Objective-Vascular extracellular matrix stiffening is a risk factor for aortic and coronary artery disease. How matrix stiffening regulates the transcriptome profile of human aortic and coronary vascular smooth muscle cells (VSMCs) is not well understood. Furthermore, the role of long noncoding RNAs (lncRNAs) in the cellular response to stiffening has never been explored. This study characterizes the stiffness-sensitive (SS) transcriptome of human aortic and coronary VSMCs and identifies potential key lncRNA regulators of stiffness-dependent VSMC functions. Approach and Results-Aortic and coronary VSMCs were cultured on hydrogel substrates mimicking physiological and pathological extracellular matrix stiffness. Total RNAseq was performed to compare the SS transcriptome profiles of aortic and coronary VSMCs. We identified 3098 genes (2842 protein coding and 157 lncRNA) that were stiffness sensitive in both aortic and coronary VSMCs (false discovery rate <1%). Hierarchical clustering revealed that aortic and coronary VSMCs grouped by stiffness rather than cell origin. Conservation analyses also revealed that SS genes were more conserved than stiffness-insensitive genes. These VSMC SS genes were less tissue-type specific and expressed in more tissues than stiffness-insensitive genes. Using unbiased systems analyses, we identified MALAT1 as an SS lncRNA that regulates stiffness-dependent VSMC proliferation and migration in vitro and in vivo. Conclusions-This study provides the transcriptomic landscape of human aortic and coronary VSMCs in response to extracellular matrix stiffness and identifies novel SS human lncRNAs. Our data suggest that the SS transcriptome is evolutionarily important to VSMCs function and that SS lncRNAs can act as regulators of stiffness-dependent phenotypes. Visual Overview-An online visual overview is available for this article. 
V ascular stiffening is associated with aging, hypertension, diabetes mellitus, and several genetic disorders and is recognized as a risk factor for cardiovascular disease. [1] [2] [3] [4] Several studies demonstrate that vascular smooth muscle cells (VSMCs) respond to extracellular matrix (ECM) stiffness by proliferating, migrating, and further remodeling the vascular ECM, thus contributing to atherosclerosis and hypertension in animal models. [5] [6] [7] However, the detailed transcriptomic response of VSMCs to experimental variation in ECM stiffness has never been investigated.
Furthermore, VSMCs are diverse and heterogeneous across the vasculature resulting from distinct embryological origins and are exposed to diverse microenvironmental, mechanical, and biochemical cues. Although some studies have shown that vascular cells from different developmental origins have different transcriptome programs and can respond differently to mechanical and biochemical factors, [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] other studies suggest that vascular cells from differing origins are stable and maintain their properties when transplanted to different microenvironments. 12, 16, 18, 19 In particular, the VSMCs of the proximal aorta and coronary arteries arise separately from the neural crest and proepicardium, respectively, 12, 20 and thus may respond differently to pathological ECM stiffening, contributing to differences in aortic and coronary artery disease. To date, most studies have predominantly used noncoronary and nonhuman models to elucidate VSMC responses to ECM stiffness. 5, 7, [21] [22] [23] [24] [25] [26] [27] Long noncoding RNAs (lncRNAs) contribute to transcriptome complexity and may account for cell-type and functional diversity. Several lncRNAs have been implicated in biological, developmental, and pathological processes and act through mechanisms such as chromatin modifications, cis-regulation of target genes, and post-transcriptional regulation of mRNA processing. [28] [29] [30] Several lncRNAs such as SENCR, lincRNA-p21, MYOSLID, and SMILR have been linked to VSMC functions. [31] [32] [33] [34] [35] Here, we present a comprehensive analysis of the SS transcriptome in human aortic and coronary VSMCs. We used engineered hydrogel substrates tuned to physiological and pathological arterial stiffness and profile donor-matched aortic and coronary VSMCs. Our data suggest that the SS transcriptome is evolutionarily important to VSMCs function and that SS lncRNAs can act as regulators of stiffness-dependent phenotypes.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

The Stiffness Transcriptome Landscape of Coronary and Aortic SMCs in Culture
We implemented deep RNA sequencing to comprehensively define gene expression in donor-matched aortic and coronary smooth muscle cells in response to physiologically soft and pathologically stiff hydrogel matrices ( Figure 1A) . Using GENCODE annotations, we identified a total of 17 716 genes expressed in either aortic or coronary VSMCs and in either soft or stiff conditions ( Figure 1B) ; 93.2% were expressed in both cell lineages (DESeq2 mean normalized counts >8). Of all expressed genes, 13 574 were protein-coding genes, and 2379 were lncRNAs. Further inspection revealed that protein-coding genes are more commonly expressed in both lineages of VSMCs than lncRNAs (95.7% versus 82.9%). These proportions are consistent with expression data obtained from whole human coronary and aortic tissues in the Genotype-Tissue Expression database ( Figure IA in the online-only Data Supplement). The uniquely expressed lncRNAs (17.1%) and protein-coding genes (4.3%) may represent contributions from the unique developmental origins of aortic and coronary VSMCs.
Principal component analysis of the top 500 most variant genes revealed that matrix stiffness is a major contributor to expression differences and accounts for ≈54% of variation between transcriptomes. VSMC origin is also a major contributor accounting for ≈36% of the expression variance ( Figure 1C) . Consistent with this analysis, unsupervised hierarchical clustering with the 500 most variant genes revealed that aortic and coronary VSMCs cultured on the same matrix stiffness clustered together ( Figure 1D ). This clustering is similar when clustering based only on proteincoding genes or even lncRNAs despite their reduced overlap in expression between aortic and coronary VSMCs ( Figure IB in the online-only Data Supplement).
Global Characteristics of SS LncRNAs and Protein-Coding Genes
We conducted pairwise differential expression analysis and found that a total of 5818 genes are matrix SS in either aortic or coronary VSMCs (false discovery rate <1%; Figure 2A and 2B). From here on, we will define an SS gene as one of the following: a gene identified as SS in only aortic or only coronary VSMCs will be referred to a UNIQUE-SS gene; a gene identified as SS in both aortic and coronary VMSC will be referred to as a COMMON-SS gene. The gene set formed by the union of all UNIQUE-SS genes and COMMON-SS genes will be referred to as ALL-SS genes.
Of the genes identified as SS, 3098 (53.2%) are COMMON-SS, with 2842 being protein-coding genes and 157 being lncRNAs. Interestingly, SS lncRNAs are more likely to be identified as UNIQUE-SS than SS protein-coding genes. That is, the percentage of UNIQUE-SS in ALL-SS of lncRNAs (57%, 206/363) is greater than the percentage of UNIQUE-SS protein-coding genes (45.5%, 2377/5219). We also found that ALL-SS genes were more likely to be expressed in both VSMC lineages than stiffness-insensitive genes. We observed that 93% of ALL-SS lncRNAs and 88% of UNIQUE-SS lncRNAs were expressed in both VSMC lineages compared with only 83% of stiffness-insensitive lncRNAs ( Figure IIA and IIB in the online-only Data Supplement). Similarly, 98% of ALL-SS protein-coding genes and 97% of UNIQUE protein-coding genes were expressed in both VSMC lineages compared with 96% of stiffness-insensitive protein-coding genes ( Figure IIA and IIB in the online-only Data Supplement). These observations suggest that the expression of SS genes is not cell-type specific and that the SS transcriptome may be generally conserved.
Indeed, we find that SS genes were significantly more conserved at sequence level using phastCons scores ( Figure 2D ). SS protein-coding genes and lncRNAs both exhibited increased conservation over stiffness-insensitive genes. Furthermore, using data from the Genotype-Tissue Expression project, we find that SS genes are expressed (cutoff of RPKM [reads per kilobase per million mapped reads] >0.7) in more tissue types than stiffnessinsensitive genes ( Figure 2D ). The SS transcriptome seems to be a conserved cellular response, which suggests that SS lncRNAs, by way of their increased conservation across species and tissue types, may control stiffness-dependent functions.
Coordinated Expression of SS LncRNA/Protein-Coding Pairs
LncRNAs and their neighboring genes are often correlated in their gene-level expression, and several studies have demonstrated that lncRNAs may regulate the expression of neighboring coding genes through various mechanisms. 29, 39, 40 We asked whether the VSMCs transcriptome-wide stiffness response Table. The full list is presented in Table III in the online-only Data Supplement. Notably, we find that the lncRNA, RP5-973M2.2 (PACER), is highly associated with the gene expression of PTGS2. PACER has been shown to positively regulate PTGS2 expression in several cell types, 41 ,42 and we and others have shown that PTGS2 is important in stiffness sensing and contributes to vascular stiffening. 5, 43 Furthermore, several lncRNAs are significantly correlated to matrix and cytoskeletal proteins that may potentially be involved in VSMC stiffness sensing. EDIL3 (Del-1) is an ECM protein that regulates VSMC adhesion, migration, and proliferation. 44 Two nuclear membrane-associated proteins are also highly correlated to SS lncRNAs. SYNE3 (aka Nesprin-3), a component of the LINC (linker of the nucleoskeleton and cytoskeleton) complex which transmits mechanical stress from cytoskeleton to the nucleus, may be important in the stiffness-mediated transcriptional response. 45 LEM-domain containing nuclear membrane protein which binds Lamin A, much like Emerin, a critical regulator of nuclear mechanotransduction.
49-51
Identification of LncRNA Regulators of Stiffness-Dependent Cell Responses
Most lncRNAs have no known function, and none have been implicated in the response to ECM stiffening. To identify lncRNAs that may play a role in stiffness-mediated cellular responses, we performed unbiased enrichment analyses ( Figure 2C ) and identified several highly enriched cellular processes in both aortic and coronary VSMCs: cell cycle, growth, death, motility, morphology, and RNA post-transcriptional modifications (splicing). Among these categories, MALAT1 was the most overrepresented lncRNA annotated to these functions (Tables I and II in the online-only Data  Supplement) . MALAT1, a highly conserved lncRNA, has been primarily implicated in cancer biology and, more recently, in endothelial cell function. Whether MALAT1 plays a role in VSMCs or in stiffness-dependent functions is unknown.
Real-time PCR validated the RNA-seq finding that matrix stiffening reduces MALAT1 expression in both aortic and coronary VSMCs ( Figure 3A ; Figure . Taken together, these data show that MALAT1 is a positive regulator of VSMC proliferation and migration in response to ECM stiffness. ECM stiffness negatively regulates MALAT1, and this may represent a homeostatic negative feedback mechanism in which the reduction in MALAT1 limits stiffness-induced proliferation and migration.
MALAT1 Is a Key LncRNA Regulator of the In Vivo Vascular Injury Response
We next asked whether MALAT1 plays a role during in vivo pathological vascular stiffening by using the mouse femoral Top significantly correlated SS lncRNAs/SS PCG gene pairs. Each correlated gene pair is listed along with the log 2 fold change for each gene by stiffness (Log 2 FC>0 represents decreased expression by stiffness), the distance between the lncRNA and PCG (in kilobases), the Spearman correlation coefficient, and the P value of the correlation. LncRNA indicates long noncoding RNA; and PCG, protein coding gene. artery wire injury model. In this model, wire-mediated endothelial injury leads to vascular matrix stiffening, neointima formation, and luminal stenosis largely driven by VSMC proliferation and migration. 27, 52 Uninjured arteries in the Malat1-knockout mice were largely similar to wild-type uninjured arteries-no appreciable neointima and comparable medial areas ( Figure 4A and 4B). This is consistent with previous reports that Malat1-knockout mice develop normally. [53] [54] [55] However, after vascular injury, Malat1-knockout mice had significantly reduced neointima formation, neointima/media ratios, and percent luminal stenosis compared with wild-type mice (Figure 4 ). These results demonstrate that MALAT1 is an important regulator of the vascular injury response and may prevent in vivo VSMC proliferation and migration during vascular stiffening.
Discussion
Although vascular stiffness has been identified as an important risk factor for cardiovascular disease, our understanding . Right, MALAT1 expression validation by quantitative PCR in primary Co and Ao VSMCs (n=5 Co VSMCs, n=4 Ao VSMCs, **P<0.005). B, MALAT1 knockdown using LNA-GapmeRs in primary Co VSMCs. C, Phase image of primary Co VSMCs cultured on tissue culture plastic for 48 h in SmGm2 (smooth muscle growth medium-2) after MALAT1 knockdown. Scale bar=100 μm. D, Primary Co VSMCs cultured on soft and stiff hydrogels for 48 h with serum containing EdU (5-ethynyl-2'-deoxyuridine). Values are normalized to nontargeting control LNA-GapmeR on soft hydrogels (n=4, **P<0.005; ****P<0.0001). E, Normalized median velocity, total distance (path dependent) migrated, and total displacement (path independent) migrated in primary Co VSMCs over 5 h. Values are normalized to velocity and distance in nontargeting control LNA-GapmeR on soft hydrogels. (n=4, *P<0.05, **P<0.005, 2-way ANOVA; Holm-Sidak multiple comparisons test.) ASO indicates antisense oligonucleotide; and LNA, locked-nucleic acid.
of how vascular stiffness alters vascular cellular behavior is incomplete. This study provides a comprehensive analysis comparing the SS transcriptome in human aortic and coronary VSMCs with a focus on lncRNAs. We found that aortic and coronary VSMC transcriptome profiles are significantly dictated by matrix stiffness and that SS genes (whether protein coding or lncRNA) are more commonly coexpressed in aortic and coronary VSMCs compared with stiffness-insensitive genes. We also found that VSMC SS genes are overall more species conserved and expressed in more tissue types than stiffness-insensitive genes. Furthermore, we observed that SS lncRNAs may be more cell lineage specific (between aortic and coronary VSMCs) than SS protein-coding genes. Using unbiased bioinformatic approaches, we predicted and confirmed that MALAT1 is an SS lncRNA that regulates stiffnessmediated VSMC proliferation and migration. These insights expand our knowledge of the basic cellular responses to pathological stiffening and human vascular disease mechanisms.
We find that ECM stiffness significantly dictates the transcriptomic identity of aortic and coronary VSMCs. Our clustering analysis suggests that ECM stiffness may override the embryological lineage contributions to the transcriptome; the transcriptome of coronary VSMCs/ stiff matrix is more similar to aortic VSMCs/stiff matrix than coronary VSMCs/soft matrix. Prior studies have suggested that VSMCs from different embryological origins are rather phenotypically stable even when transplanted into disparate vascular microenvironments [16] [17] [18] ; however, these transplantation studies are uncontrolled for any particular microenvironmental parameter. By using donor-matched aortic and coronary VSMCs, any differences we observe in the transcriptome of aortic and coronary VSMCs arise from contributions from embryological lineage programs or the effect of ECM stiffness.
Several studies support this notion that ECM stiffness may significantly dictate cell transcriptomic identity. ECM stiffness and other mechanical parameters are critical in tissue and organ development. 56 Early studies demonstrated that ECM stiffness can dictate stem cell fate and that different stiffness can promote different lineages. [57] [58] [59] [60] ECM stiffness has also been shown to alter nuclear mechanics, chromatin organization, and the activity of a variety of ubiquitous transcription factors in multiple cell types, leading to global transcription changes. [61] [62] [63] [64] [65] In further support of this idea, we found that SS genes identified as SS in either aortic or coronary VSMCs tended to be expressed in both VSMC lineages and across more tissue types than stiffness-insensitive genes. These SS genes were also more conserved across species at the sequence level. This suggests that the SS gene set may represent a critical response module across many cell and tissue types that regulates cellubiquitous processes, as predicted by pathway enrichment analysis.
In this study, we found that SS lncRNAs were significantly correlated with more of their nearby genes when compared with stiffness-insensitive lncRNAs. Suggesting that SS lncRNAs may coordinate stiffness-dependent protein-coding gene expression. Indeed, some of the lncRNAs in the Table may not be functionally linked to their correlated proteincoding gene, whereas others may represent true cis-regulatory lncRNAs and directly control the gene expression of nearby protein-coding genes. Cross-sections of injured and uninjured (contralateral) femoral arteries of wildtype (WT) and MALAT1-knockout (KO) adult mice were stained for elastin to visualize the internal and external elastic lamina. The dashed red line delineates the internal elastic lamina, which circumscribes the neointima. Scale bar=100 µm. B, Areas of the media and neointima from injured femoral arteries (inj-media, inj-neointima) and uninjured femoral arteries (uninj-media) of WT and KO mice. C, Neointimal-media area ratios of injured WT and KO femoral arteries. D, Percent stenosis was calculated by dividing the neointimal area by the area circumscribed by the internal elastic lamina×100%. (n=7 WT, n=5 MALAT1-KO, **P<0.005, ns=not significant, Mann-Whitney Test.) a.u. indicates arbitrary units.
Among the top 20 correlated lncRNAs in the Table, only 2 have been previously studied: CASC15 and RP5-973M2.2 (PACER), and both have been shown to regulate coding gene expression and in particular PACER was shown to be a cisregulator of its neighboring coding gene PTGS2. 41, 66, 67 Analysis of stiffness-enriched pathways and gene sets for SS lncRNAs allowed us to identify MALAT1 as an lncRNA regulator of VSMC stiffness-dependent proliferation and migration. This study implicates a role for MALAT1 in VSMCs and its interplay with matrix stiffness. MALAT1 had previously been linked to tumor aggressiveness in in vitro and clinical studies. [68] [69] [70] [71] [72] [73] [74] However, its importance in vascular disease is relatively unknown, with only 1 study implicating MALAT1 in endothelial cell function. 75 Although we found that MALAT1-dependent proliferation is similar in both VSMCs and endothelial cells, MALAT1 knockdown enhances migration in endothelial cells while reducing migration in VSMCs. Our study also identified splicing as a significant stiffness-mediated pathway for which MALAT1 has a documented role. Whether stiffness regulates RNA splicing and whether MALAT1 regulates splicing in VSMCs will require future work.
Interestingly, despite many studies linking MALAT1 to critical cell functions, MALAT1 whole-body knockout mice develop normally. [53] [54] [55] We hypothesize that MALAT1 is dispensable during physiological/normal conditions, but is necessary for critical cell functions such as proliferation and migration during pathological/abnormal stiffening conditions. In support of this, most in vitro studies have interrogated MALAT1 using only supraphysiologically stiff tissue culture plastic, whereas our data further demonstrate that MALAT1 is necessary for VSMC proliferation and migration in stiff context (stiff hydrogels and vascular injury) and is less important in physiologically soft context (soft hydrogels and uninjured arteries). These findings also suggest that MALAT1 may serve as a potential therapeutic target as the loss of MALAT1 prevented neointimal formation and luminal stenosis in injured arteries with limited effects on healthy/ uninjured arteries.
We also find that MALAT1 expression is reduced by ECM stiffness in VSMCs and perhaps acts in a negative feedback mechanism to limit stiffness-mediated proliferation and migration. However, this effect may not necessarily be universal. Real-time PCR validated the stiffness-mediated reduction in MALAT1 in the donor-matched aortic and coronary VSMCs used for the RNAseq. We also validated this finding in several different donors of aortic and coronary VSMCs, but not in all donors. We think that there may be a level of donor variability in VSMCs, where specific donors may exhibit stiffness-mediated MALAT1 reduction while others do not. This potential variability may reflect differences in the risk for cardiovascular disease from vascular stiffness in various populations. 76, 77 In summary, pathological matrix stiffening is a major regulator of both human aortic and coronary VSMC transcriptomes and function. Our study demonstrates that lncRNAs respond to ECM stiffening and regulate VSMC cellular functions. We also identify SS lncRNAs that may coordinate the expression of nearby protein-coding genes involved in the response to ECM stiffening. Yet, many SS lncRNAs identified in this study have no known or predicted function. Further studies to understand the complex response to ECM stiffening may help identify novel diagnostic and therapeutic targets for vascular stiffness.
